Clinical Trial Update: Study of Aldurazyme® Replacement Therapy in Patients With Mucopolysaccharidosis I (MPS I) Disease [Phase 3]

View source ↗

Summary

Phase 3 study of Aldurazyme (laronidase) for mucopolysaccharidosis I has completed, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hurler Syndrome
• Hurler-scheie Syndrome
• Mucopolysaccharidosis
• Scheie Syndrome

Drugs mentioned

• Aldurazyme (Laronidase)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Mucopolysaccharidosis I, Hurler Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2009-02-12